Hybridoma technologies for antibody production

Immunotherapy

Volumn 3, Issue 3, 2011, Pages 371-380

  Tomita, Masahiro ^a   Tsumoto, Kanta ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

antigen based selection; B lymphocyte; biotin avidin interaction; electrical pulse; hybridoma cell; immunoglobulin receptor; monoclonal antibody; myeloma cell; selective fusion

Indexed keywords

IMMUNOGLOBULIN RECEPTOR; MONOCLONAL ANTIBODY;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CELL FUSION; CELL SELECTION; HUMAN; HYBRIDOMA; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MEDICAL TECHNOLOGY; MYELOMA CELL; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ANTIGENS; B-LYMPHOCYTES; CELL FUSION; CELL LINE; CROSS-LINKING REAGENTS; EFFICIENCY; ELECTRICITY; HUMANS; HYBRIDOMAS; LASERS; MICE; MODELS, BIOLOGICAL; MULTIPLE MYELOMA; POLYETHYLENE GLYCOLS;

EID: 79952639529     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/imt.11.4     Document Type: Review

References (55)

1. Köhler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256(5517), 495-497 (1975).
2. Benjamini E, Coico R, Sunshine G: Immunology, a Short Course (Fourth Edition). Wiley-Blackwell, NY, USA(2000).
3. de StGroth SF, Scheidegger D: Production of monoclonal antibodies: strategy and tactics. J. Immunol. Methods 35(1-2), 1-21 (1980). (Pubitemid 10034772)
4. Zimmermann U: Electric field-mediated fusion and related electrical phenomena. Biochim. Biophys. Acta 694(3), 227-277 (1982).
5. Ohkohchi N, Itagaki H, Doi H, Taguchi Y, Satomi S, Satoh S: New technique for producing hybridoma by using laser radiation. Lasers Surg. Med. 27(3), 262-268 (2000).
6. Lo MMS, Tsong TY, Conrad MK, Strittmatter SM, Hester LD, Snyder SH: Monoclonal antibody production by receptor-mediated electrically induced cell fusion. Nature 310(5980), 792-794 (1984). (Pubitemid 14057662)
7. Tsong TY, Tomita M, Lo MMS: Pre-selection of B-lymphocytes by antigen for fusion to myeloma cells by pulsed electric field (PEF) method. In:Molecular Mechanisms of Membrane Fusion . Ohki S, Doyle D, Flanagan TD, Hui SW, Mayhew E (Eds). Plenum, NY, USA, 223-236 (1988).
8. Tomita M, Tsong TY: Selective production of hybridoma cells: antigenic-based pre-selection of B lymphocytes for electrofusion with myeloma cells. Biochim. Biophys. Acta 1055(3), 199-206 (1990).
9. Tsong TY, Tomita M: Selective B lymphocyte-myeloma cell fusion. Methods Enzymol. 220, 238-246 (1993).
10. Tomita M, Sugi H, Ozawa K, Tsong TY, Yoshimura T: Targeting antigen-specific receptors on B lymphocytes to generate high yields of specific monoclonal antibodies directed against biologically active lower antigenic peptides within presenilin 1. J. Immunol. Methods 251(1-2), 31-43 (2001). (Pubitemid 32261054)
11. Tomita M, Fukuda T, Ozu A, Kimura K, Tsong TY, Yoshimura T: Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity. Hybridoma (Larchmt) 25(5), 283-292 (2006). (Pubitemid 46417136)
12. Tomita M: Next generation of monoclonal antibodies. BIOforum Europe 12(4), 33-34 (2008).
13. Tomita M: Anovel method for generation of monoclonal antibodies. In:Biochemistry and Histocytochemistry Research Developments (Expert Commentary) . Fuchs S, Auer M (Eds). Nova Science Publishers, NY, USA, 335-336 (2010).
14. Tomita M, Tsumoto K: Recent advances in antigen-based generation of monoclonal antibodies. Curr. Immunol. Rev. 6(1), 56-61 (2010).
15. Chaiet L, Wolf FJ: The properties of streptavidin, a biotin-binding protein produced by streptomycetes. Arch. Biochem. Biophys. 106, 1-5 (1964).
16. Green NM: Avidin. Adv. Protein Chem. 29, 85-133 (1975).
17. Wojchowski DM, Sytkowski AJ: Hybridoma production by simplified avidin-mediated electrofusion. J. Immunol. Methods 90(2), 173-177 (1986). (Pubitemid 16089008)
18. Hewish DR, Werkmeister JA: The use of an electroporation apparatus for the production of murine hybridomas. J. Immunol. Methods 120(2), 285-289 (1989). (Pubitemid 19160439)
19. Werkmeister JA, Tebb TA, Kirkpatrick A, Shukla DD: The use of peptide-mediated electrofusion to select monoclonal antibodies directed against specific and homologous regions of the potyvirus coat protein. J. Immunol. Methods 143(2), 151-157 (1991).
20. Woolley DW, Longsworth LG: Isolation of an antibiotin factor from egg white. J. Biol. Chem. 142(1), 285-290 (1942).
21. Tomita M, Yokota T, Wada M et al.: Nanosensing measurement using novel monoclonal antibodies generated by B-cell targeting. FEBS J. 275(Suppl. 1), 373 (2008).
22. Boss BD: An improved in vitro immunization procedure for the production of monoclonal antibodies. Methods Enzymol. 121, 27-33 (1986). (Pubitemid 16057881)
23. Tomita M, Taniguchi T, Tanaka J et al.: Generation of monoclonal antibodies directed against peptide sequences by a B cell targeting technique. Hum. Antibodies 12(1-2), 37-39 (2003).
24. Tomita M, Sugao M, Taniguchi T et al.: Antigen-based B cell targeting technique to generate high yields of monoclonal antibodies. Hum. Antibodies 13(1-2), 42 (2004).
25. Tomita M, Taniguchi T, Sawada H, Nishino N, Yoshimura T: Rapid generation of monoclonal antibodies against the epitope sequences of human insulin using an in vitro immunization method. Peptide Sci. 469-472 (2004).
26. Tomita M, Asaoka Y, Kato Y, Ogata S, Tsong TY, Yoshimura T: Anew technology for the generation of novel monoclonal antibodies based on short-term immunization. Peptide Sci. 105-108 (2006).
27. Tomita M, Asaoka Y, Fukuda T et al.: Rapid and selective production of hybridoma cells secreting novel monoclonal antibodies based on short-term immunization. Hum. Antibodies 15(1-2), 33-35 (2006). (Pubitemid 43864791)
28. Gavilondo JV, Larrick JW: Antibody engineering at the millennium. BioTechniques 29(1), 128-145 (2000). (Pubitemid 30439427)
29. Konthur Z, Hust M, Dübel S: Perspectives for systematic in vitro antibody generation. Gene 364, 19-29 (2005). (Pubitemid 41773230)
30. Wark KL, Hudson PJ: Latest technologies for the enhancement of antibody affinity. Adv. Drug Deliv. Rev. 58(5-6), 657-670 (2006). (Pubitemid 44247225)
31. Bradbury AR, Marks JD: Antibodies from phage antibody libraries. J. Immunol. Methods 290(1-2), 29-49 (2004).
32. Border ET, Midelfort KS, Wittrup KD: Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc. Natl Acad. Sci. USA 97(20), 10701-10705 (2000).
33. Feldhaus MJ, Siegel RW: Yeast display of antibody fragments: a discovery and characterization platform. J. Immunol. Methods 290(1-2), 69-80 (2004). (Pubitemid 38917131)
34. Lipovsek D, Plückthun A: In-vitro protein evolution by ribosome display and mRNAdisplay. J. Immunol. Methods 290(1-2), 51-67 (2004). (Pubitemid 38917130)
35. Lovborg U: Monoclonal Antibodies: Production and Maintenance. William Heinemann Medical Books, London, UK (1982).
36. Tomita M, Furuta K, Sano Y, Tsumoto K: Multiple generation of novel monoclonal antibodies based on B-cell targeting. FEBS J. 276(Suppl. 1), 293 (2009).
37. TOMITAM, MATSUBAT: JP4599527 (2010).
38. Tomita M, Hirano M, Watanabe E et al.: A new technology for intact antigen-based and receptor-mediated generation of novel monoclonal antibodies. Hum. Antibodies 16(1-2), 40-41 (2007).
39. Tomita M, Tsumoto K: New hybridoma technology based on antigen-specific immunoglobulin receptors. FEBS J. 277(Suppl. 1), 50 (2010).
40. Lonberg N, Taylor LD, Harding FAet al.: Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 368(6474), 856-859 (1994). (Pubitemid 24137750)
41. Green LL, Hardy MC, Maynard-Currie CE et al.: Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat. Genet. 7(1), 13-21 (1994). (Pubitemid 24232374)
42. Jakobovits A: Production of fully human antibodies by transgenic mice. Curr. Opin. Biotechnol. 6(5), 561-566 (1995).
43. Matsumoto N, Matsue T, Uchida I: Paired cell alignment using jagged microarray electrode. Bioelectrochem. Bioenerg. 34(2), 199-202 (1994). (Pubitemid 2129346)
44. Ho CT, Lin RZ, Chang WY, Chang HY, Liu CH: Rapid heterogeneous liver-cell on-chip patterning via the enhanced field-induced dielectrophoresis trap. Lab. Chip 6(6), 724-734 (2006).
45. Heida T, Rutten WLC, Marani E: Dielectrophoretic trapping of dissociated fetal cortical rat neurons. IEEE Trans. Biomed. Eng. 48(8), 921-930 (2001). (Pubitemid 32703044)
46. Gray DS, Tan JL, Voldman J, Chen CS: Dielectrophoretic registration of living cells to a microelectrode array. Biosens. Bioelectron. 19(12), 1765-1774 (2004).
47. Yu Z, Xiang G, Pan L et al.: Negative dielectrophoretic force assisted construction of ordered neuronal networks on cell positioning bioelectronic chips. Biomed. Microdevices 6(4), 311-324 (2004). (Pubitemid 39545750)
48. Suzuki M, Yasukawa T, Shiku H, Matsue T: Negative dielectrophoretic patterning with different cell types. Biosens. Bioelectron. 24(4), 1043-1047 (2008).
49. Jat PS, Noble MD, Ataliotis P et al.: Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc. Natl Acad. Sci. USA 88(12), 5096-5100 (1991). (Pubitemid 21914690)
50. Pasqualini R, Arap W: Hybridoma-free generation of monoclonal antibodies. Proc. Natl Acad. Sci. USA 101(1), 257-259 (2004). (Pubitemid 38084237)
51. Matsuba T, Mitoma Y, Tanaka C, Inoue M: Preparation of super-high affinity rabbit monoclonal antibodies against estradiol. Application to highly sensitive estradiol measurement. Tosoh Res. Technol. Rev. 52, 3-9 (2008).
52. MATSUBAT: JP2009240300 (2009).
53. MASUBUCHIH, HASHIMOTO S: JP1998262657 (1998).
54. Zhou X, Hu W, Qin X: The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy. Oncologist 13(9), 954-966 (2008).
55. Kubota T, Niwa R, Satoh M, Akinaga S, Shitara K, Hanai N: Engineered therapeutic antibodies with improved effector functions. Cancer Sci. 100 (9), 1566-1572 (2009).